Given the importance of cardiac hypertrophy and serum aldosterone levels as independent cardiovascular disease risk factors, this observation indicates that some of the differences observed for males and females in the clinical setting may also have an MR-dependent mechanism. Here, NR3C2 is linked to cardiac hypertrophy.